NASDAQ Rheumatology Market News
MorphoSys gibt bekannt, dass sein Lizenznehmer Janssen positive klinische Daten für Guselkumab in Psoriasis-Arthritis vorgestellt hat
Martinsried / Munich, Germany, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Die MorphoSys AG (Frankfurt: ...
MorphoSys Announces That Its Licensee Janssen Has Presented Positive Clinical Data of Guselkumab in Psoriatic Arthritis
Martinsried / Munich, Germany, Nov. 15, 2016 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; ...
Oncobiologics Announces Presentation of Final Data from Phase 1 Clinical Study of ONS-3010 (HUMIRA® Biosimilar)
CRANBURY, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...
Oncobiologics Announces Presentation of Final Data from Phase 1 Clinical Study of ONS-3010 (HUMIRA® Biosimilar)
CRANBURY, N.J., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS), a clinical-stage biopharmaceutical ...
Horizon Pharma plc Presents Data on KRYSTEXXA® (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting
DUBLIN, Ireland, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...
Horizon Pharma plc Presents Data on KRYSTEXXA® (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting
DUBLIN, Ireland, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical ...
Novartis presents new Cosentyx data showing long-lasting efficacy in psoriatic arthritis over 3 years including patient-reported pain
Cosentyx® data show sustained improvements in the signs and symptoms of psoriatic arthritis (PsA) ...
Novartis presents new Cosentyx data showing long-lasting efficacy in psoriatic arthritis over 3 years including patient-reported pain
Cosentyx® data show sustained improvements in the signs and symptoms of psoriatic arthritis (PsA) ...
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting
SALT LAKE CITY, Nov. 12, 2016 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary ...
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting
SALT LAKE CITY, Nov. 12, 2016 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary ...
Horizon Pharma plc Selected as One of Chicago Tribune’s 2016 Top Workplaces
LAKE FOREST, Ill., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) a biopharmaceutical ...
Horizon Pharma plc Selected as One of Chicago Tribune’s 2016 Top Workplaces
LAKE FOREST, Ill., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (NASDAQ:HZNP) a biopharmaceutical ...
Apricus Biosciences Provides Corporate Update and Third Quarter Financial Results
Strategic Focus on Growing Global Vitaros® Revenue and Achieving Profitability in 2017Apricus Granted Type ...